Moore Capital Management, LP Merck & Co., Inc. Transaction History

Moore Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $11.5 Million - $12.5 Million	115,000 Added 460.0%	140,000 $15.3 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $4.63 Million - $5.14 Million	-45,000 Reduced 64.29%	25,000 $2.57 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $5.43 Million - $5.92 Million	50,000 Added 250.0%	70,000 $8.08 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $2.06 Million - $2.3 Million	20,000 New	20,000 $2.13 Million

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $256B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.